BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32529140)

  • 1. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.
    Yu NY; DeWees TA; Liu C; Daniels TB; Ashman JB; Beamer SE; Jaroszewski DE; Ross HJ; Paripati HR; Rwigema JM; Ding JX; Shan J; Liu W; Schild SE; Sio TT
    Adv Radiat Oncol; 2020; 5(3):450-458. PubMed ID: 32529140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
    Yu NY; DeWees TA; Voss MM; Breen WG; Chiang JS; Ding JX; Daniels TB; Owen D; Olivier KR; Garces YI; Park SS; Sarkaria JN; Yang P; Savvides PS; Ernani V; Liu W; Schild SE; Merrell KW; Sio TT
    Clin Lung Cancer; 2022 Dec; 23(8):e526-e535. PubMed ID: 36104272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
    Bhangoo RS; DeWees TA; Yu NY; Ding JX; Liu C; Golafshar MA; Rule WG; Vora SA; Ross HJ; Ahn DH; Beamer SE; Jaroszewski DE; Hallemeier CL; Liu W; Ashman JB; Sio TT
    Adv Radiat Oncol; 2020; 5(5):871-879. PubMed ID: 33083649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
    Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
    JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
    Gjyshi O; Xu T; Elhammali A; Boyce-Fappiano D; Chun SG; Gandhi S; Lee P; Chen AB; Lin SH; Chang JY; Tsao A; Gay CM; Zhu XR; Zhang X; Heymach JV; Fossella FV; Lu C; Nguyen QN; Liao Z
    J Thorac Oncol; 2021 Feb; 16(2):269-277. PubMed ID: 33198942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
    Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients.
    Yoon HG; Ahn YC; Oh D; Noh JM; Park SG; Nam H; Ju SG; Kwon D; Park S
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33801766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus.
    Mohiuddin JJ; Jethwa KR; Grandhi N; Breen WG; Wang X; Anvari A; Lin H; Sandhyavenu H; Doucette A; Plastaras JP; Rule WG; Metz JM; Merrell KW; Sio TT; Ashman JB; Haddock MG; Ben-Josef E; Hallemeier CL; Wojcieszynski AP
    Adv Radiat Oncol; 2021; 6(5):100744. PubMed ID: 34646965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal Cancer Outcomes After Definitive Chemotherapy With Intensity Modulated Proton Therapy.
    Abana CO; Damen PJ; van Rossum PS; Bravo PL; Wei X; Pollard-Larkin JM; Nitsch PL; Murphy MB; Hofstetter WL; Liao Z; Lin SH
    Int J Part Ther; 2024 Mar; 11():100009. PubMed ID: 38757075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC.
    Patel JS; McCall NS; Thomas M; Zhou J; Higgins KA; Bradley JD; Tian S; McDonald MW; Kesarwala AH; Stokes WA
    Int J Part Ther; 2024 Jun; 12():100016. PubMed ID: 38832321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Fan M; Kang JJ; Lee A; Fan D; Wang H; Kitpanit S; Fox P; Sine K; Mah D; McBride SM; Tsai CJ; Riaz N; Dunn LA; Sherman EJ; Michel L; Singh B; Ganly I; Wong RJ; Boyle JO; Cohen MA; Lee NY
    Cancer; 2020 Jan; 126(9):1905-1916. PubMed ID: 32097507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.
    Janopaul-Naylor JR; Cao Y; McCall NS; Switchenko JM; Tian S; Chen H; Stokes WA; Kesarwala AH; McDonald MW; Shelton JW; Bradley JD; Higgins KA
    Front Oncol; 2022; 12():1074675. PubMed ID: 36733369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reirradiation of thoracic cancers with intensity modulated proton therapy.
    Ho JC; Nguyen QN; Li H; Allen PK; Zhang X; Liao Z; Zhu XR; Gomez D; Lin SH; Gillin M; Komaki R; Hahn S; Chang JY
    Pract Radiat Oncol; 2018; 8(1):58-65. PubMed ID: 28867546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution.
    Williams VM; Parvathaneni U; Laramore GE; Aljabab S; Wong TP; Liao JJ
    Int J Part Ther; 2021; 8(2):28-40. PubMed ID: 34722809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
    Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
    Zhang X; Li Y; Pan X; Xiaoqiang L; Mohan R; Komaki R; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):357-66. PubMed ID: 19660879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.